The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The STD Diagnostics Market Progress Between 2026 And 2030?
The std diagnostics market size has seen rapid expansion in recent years. It is anticipated to increase from $10.77 billion in 2025 to $11.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The growth observed in the historic period can be attributed to the increasing prevalence of sexually transmitted infections, the expansion of diagnostic laboratory infrastructure, the growth of public health screening programs, rising awareness of sexual health, and the availability of advanced nucleic acid testing.
The std diagnostics market is projected to experience swift expansion over the coming years, anticipated to reach $17.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors driving this growth during the forecast period include a heightened need for swift diagnostic tools, greater uptake of at-home testing solutions, wider integration of molecular diagnostics, increased funding for public health monitoring, and an emphasis on private and readily available testing services. Key trends expected during this period involve the wider acceptance of rapid and point-of-care STD tests, increased application of molecular diagnostic technologies, the expanding incorporation of automated lab systems, the proliferation of at-home STD testing options, and an elevated commitment to detecting diseases early and precisely.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
What Key Drivers Are Fueling The Growth Of The STD Diagnostics Market?
The increasing occurrence of STDs is anticipated to propel the expansion of the STD diagnostics market in the future. Sexually transmitted diseases, or STDs, are infections spread through sexual contact that necessitate medical diagnosis and treatment. The escalating prevalence of STDs is fueled by heightened sexual activity and evolving social behaviors among younger populations, as reduced stigma surrounding sexual health and greater mobility lead to more diverse sexual networks and higher transmission rates. This rising STD prevalence directly underpins the increased demand for diagnostic testing services and products, as healthcare providers require accurate laboratory tests, screening kits, and detection technologies to identify infections and prevent further spread. For instance, in September 2025, according to the Centers for Disease Control and Prevention, a US-based government administration, congenital syphilis rose for the twelfth consecutive year, reaching nearly 4,000 reported cases in 2024. Therefore, the expanding prevalence of STDs is a key driver for the growth of the STD diagnostics market.
Which Segment Classifications Are Used In The STD Diagnostics Market Segment Analysis?
The std diagnostics market covered in this report is segmented –
1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing
2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare
Subsegments:
1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests
2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests
3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests
4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests
5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests
6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)
7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests
What Trends Are Influencing The STD Diagnostics Market?
Major companies operating within the STD diagnostics market are dedicated to developing innovative solutions, such as real-time PCR kits, to address outstanding medical needs and enhance diagnostic proficiency. A real-time PCR kit consists of a collection of reagents necessary for performing real-time polymerase chain reaction (qPCR), a sensitive and commonly employed method for identifying and quantifying particular nucleic acid sequences. As an example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development firm, launched both the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, which are specifically formulated for the detection of Mycoplasma hominis and Treponema pallidum. Additionally, these kits are characterized by their high sensitivity and specificity, ease of use, rapid processing time, and the capability to identify multiple pathogens in one test.
Which Firms Are Contributing To The STD Diagnostics Market Ecosystem?
Major companies operating in the std diagnostics market are Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy
Get The Full STD Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Which Geographic Region Dominates The STD Diagnostics Market?
North America was the largest region in the STD diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized STD Diagnostics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Browse Through More Reports Similar to the Global STD Diagnostics Market 2026, By The Business Research Company
Sexually Transmitted Infections Stis Market Report 2026
Womens Health Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report
Companion Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model